Back to the main directory
EarningsReview / Equity
- Nobia (Hold, TP: SEK20.00) - Low risk of rights issue by DnB Markets
- Eneti Inc (Buy, TP: USD13.00) - Waiting for newbuild deliveries by DnB Markets
- Entra (Hold, TP: NOK115.00) - Volatile times, but fair EV valuation by DnB Markets
- Sampo Oyj (Buy, TP: EUR53.00) - Life under review by DnB Markets
- Alligator Bioscience (Buy, TP: SEK4.00) - Focus on next OPTIMIZE read-out by DnB Markets
- SpareBank 1 Østlandet (Buy, TP: NOK135.00) - >12% ROE target after strong Q4 by DnB Markets
- Weekly news, topics & discussion by DnB Markets
- A BUY, a HOLD, and a SELL by DnB Markets
- Thule Group - Bad ending to 2022, but back in the saddle from Q2E by Danske Bank Equity Research
- RugVista Group - Managing costs well when visibility remains low by Danske Bank Equity Research
- Kemira - Energy boost to carry through 2023 by Danske Bank Equity Research
- Boozt (Hold, TP: SEK130.00) - High uncertainty entering 2023 by DnB Markets
- Sparebanken Øst (Hold, TP: NOK52.00) - Generous dividends by DnB Markets
- Airports of Thailand (AOT TB) by HSBC
- Mahindra & Mahindra (MM IN) by HSBC
- Modern Times Group - Uncertainty remains by Danske Bank Equity Research
- Sampo - Prudent reserving, not soft underwriting by Danske Bank Equity Research
- ICE 2023: What''s the game plan? by BNP Paribas Exane
- Schibsted - Cost-cutting coming into action by Danske Bank Equity Research
- SAAB - Growth outlook clearly ahead of expectations by Danske Bank Equity Research
- Sustainability Weekly 6 – 10 February 2023 by Oddo BHF
- Investment Daily 13/02/2023 by BNP Paribas Exane
- New Wave Group - Buy/SEK 270: A good entry point after harsh share price reaction by Nordea
- Kongsberg Gruppen - Buy/NOK 425: Fundamentals support continued growth by Nordea
- Sdiptech - Buy/SEK 286 (300): No pain, no gain by Nordea
- SpareBank 1 Helgeland (Buy, TP: NOK142.00) - Generous dividends after solid Q4 by DnB Markets
- DHT Holdings (Buy, TP: USD11.70) - Premium earner by DnB Markets
- AF Gruppen (Sell, TP: NOK105.00) - Q4 broadly in line by DnB Markets
- Schibsted (Buy, TP: NOK340.00) - Gains from Adevinta revaluation by DnB Markets
- Kongsberg Gruppen (No_rec, TP: NOK) - Stage set for further growth by DnB Markets
- Seafood - Fat Trout Weekly by DnB Markets
- Valuation and market update by DnB Markets
- Höegh Autoliners ASA (Buy, TP: NOK94.00) - Plenty of cash and value by DnB Markets
- AFRY - Stuck in the starting blocks by Danske Bank Equity Research
- Boozt - Tricky H1, by Danske Bank Equity Research
- Terveystalo - Earnings recovery well on its way by Danske Bank Equity Research
- Sparebanken Sør (Buy, TP: NOK147.00) - Continued margin improvement by DnB Markets
- Balder (Hold, TP: SEK60.00) - Q4 above expectations by DnB Markets
- Aurobindo Pharma (ARBP IN) by HSBC
- Voltas (VOLT IN) by HSBC
- Grabbing the headlines, but not the margins by BNP Paribas Exane
- Hard bargains by BNP Paribas Exane
- Troubles Magna-fied by BNP Paribas Exane
- Cheap but lacking catalysts by BNP Paribas Exane
- Sustainability Weekly 06 – 10 Février 2023 by Oddo BHF
- 2022 in line - 2023/25 targets reset downwards by BNP Paribas Exane
- Sanoma - A complete reset of margin and dividend expectations by Danske Bank Equity Research
- Aker BP - Buy/NOK 370 (380): Steady as she goes by Nordea
- Olvi - Buy/EUR 36 (39): Cost inflation to hamper 2023 performance by Nordea
- Thule - Hold: Questions abound over Mr. Thule's departure by Nordea